WE FUND RESEARCH INTO ANY TYPE OF CANCER, ANYWHERE IN THE WORLD
We are a charity which funds research into any type of cancer anywhere in the world.
We fund projects in the world’s best research institutions. We fund some of the world’s most diverse and unexpected projects. We fund world-renowned specialists and up and coming talent. We do all those things for one very good reason - to gain a global perspective. Because research doesn’t happen in isolation. The answers will not come from one scientist, in one lab, in one country.
Scientists may compete to be the first to make a world-changing discovery, but they are linked together by an unflinching commitment to better understand cancer and how we can live with it. For this reason they share their discoveries. And they need to because cancer is not one disease – it’s more than 200. All different, unique diseases, which require different approaches for treatment. Treatments that work for some cancers don’t work for others and sometimes those treatments simply stop working.
This worldwide research will enhance our understanding of cancer and help us find and develop better, more effective treatments. Treatments personalised to your unique needs. Treatments you, your family or your family’s family may rely on in the future.
But research won’t happen without funding. And without research we make no further progress. Without research we stop investing in our future health.
To realise our vision of no life cut short by cancer the research can never stop.
This project hopes to identify new functions for a protein which may help us to understand how resistance to tamoxifen happens at a molecular level.
This project is testing a potential new treatment for myeloma and will investigate whether it might also help stop the myeloma itself as well as control the bone damage.
An estimated 1.24 million new cases of bowel cancer are diagnosed each year worldwide.
Donate with text - it takes less than 30 seconds.
Text WORLDWIDE to 70004 to donate £10.
whatever it takes,
wherever it takes us.